Infections associated with <scp>CAR</scp>‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies

Abstract

To enhance the infection control post-CAR-T therapy, this review proposes preventive strategies tailored to the early and long-term management of patients. It underscores the need for a nuanced understanding of infection mechanisms and the importance of personalized prevention plans to improve clinical outcomes in multiple myeloma treatment.